Standard & Poor’s has affirmed its ‘A-‘ counterparty credit and financial strength ratings and negative outlook on Amedex Insurance Co.
Standard & Poor’s subsequently withdrew the ratings at the company’s request. The ratings reflected Amedex’s good business position as a niche provider of major medical products in Latin America, favorable operating performance, and strong capitalization.
These positive factors are offset by Amedex’s limited size, declining enrollment trends, new business risk through Amedex Bermuda, and high operating expenses, which are the direct consequence of its target market and high level of service provided.
Was this article valuable?
Here are more articles you may enjoy.
Flooding in California Leads to Soaked Roads, Water Rescues and 1 Death
Jump Trading Faces $4 Billion Terraform Administrator Suit
Cat Bonds Linked to Wildfires Lose ‘Once Untouchable’ Status
‘Door Knocker’ Roofers Were Everywhere. NC Farm Bureau Saw an Opportunity